Covered recipient · General Payments record
STEPHANIE RICCI- FUHRMAN
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$3,050.32
- Reported across 162 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $349.97 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $81.17 | 4 |
| Astellas Pharma US Inc | $58.19 | 2 |
| Biogen, Inc. | $47.10 | 2 |
| Exeltis, USA Inc. | $41.00 | 2 |
| PFIZER INC. | $34.02 | 2 |
| Exact Sciences Corporation | $30.39 | 1 |
| CooperSurgical, Inc. | $23.77 | 1 |
| Organon LLC | $18.72 | 1 |
| ASCEND THERAPEUTICS US, LLC | $15.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.77 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105943589 | CMS |
| ABBVIE INC. | $19.31 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105943591 | CMS |
| ABBVIE INC. | $13.75 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105943593 | CMS |
| ABBVIE INC. | $25.34 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105943595 | CMS |
| ASCEND THERAPEUTICS US, LLC | $15.61 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146421875 | CMS |
| Astellas Pharma US Inc | $33.41 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139265200 | CMS |
| Astellas Pharma US Inc | $24.78 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139427718 | CMS |
| Biogen, Inc. | $23.19 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104831668 | CMS |
| Biogen, Inc. | $23.91 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104867450 | CMS |
| CooperSurgical, Inc. | $23.77 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150788013 | CMS |
| Exact Sciences Corporation | $30.39 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114853538 | CMS |
| Exeltis, USA Inc. | $16.89 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150002902 | CMS |
| Exeltis, USA Inc. | $24.11 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150002904 | CMS |
| Organon Llc | $18.72 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136210455 | CMS |
| PFIZER INC. | $15.37 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131696255 | CMS |
| PFIZER INC. | $18.65 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131626745 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.